NORFOLK, Va. — A research firm in Virginia says it has gotten a federal license to import high-quality extracts of marijuana for medical research.
The Virginian-Pilot reported Wednesday that Sanyal Biotechnology will soon embark on a series of critical studies into the treatment of various diseases and disorders.
Sanyal CEO Rebecca Caffrey said the license is the broadest ever issued to a U.S. company. And it allows the firm to import high-quality cannabis extracts that aren’t available in the U.S.
Dr. Caffrey said up until now, no other company has been able to take Cannabis research to this level.
“It will be extremely helpful for Americans to be able to run clinical trials, clinical studies in this country and answer those questions: is our components of Cannabis good for all these different indications and if so, what’s the best way to dose it?” said Caffrey. “We have not been able to really answer these